Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2016, Article ID 3474751, 6 pages
http://dx.doi.org/10.1155/2016/3474751
Research Article

Analysis of LRRK2, SNCA, and ITGA8 Gene Variants with Sporadic Parkinson’s Disease Susceptibility in Chinese Han Population

1Department of Neurology, The First Affiliated Hospital of Xiamen University, Xiamen, China
2The First Clinical Medical College of Fujian Medical University, Fuzhou, China
3Department of Neurology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China

Received 21 May 2016; Revised 1 July 2016; Accepted 8 August 2016

Academic Editor: Eng King Tan

Copyright © 2016 Jie Fang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Nalls, N. Pankratz, C. M. Lill et al., “Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease,” Nature Genetics, vol. 46, no. 9, pp. 989–993, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. A. L. McCormack, M. Thiruchelvam, A. B. Manning-Bog et al., “Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat,” Neurobiology of Disease, vol. 10, no. 2, pp. 119–127, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Kalinderi, S. Bostantjopoulou, and L. Fidani, “The genetic background of Parkinson's disease: current progress and future prospects,” Acta Neurologica Scandinavica, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Simón-Sánchez, C. Schulte, J. M. Bras et al., “Genome-wide association study reveals genetic risk underlying Parkinson's disease,” Nature Genetics, vol. 41, pp. 1308–1312, 2009. View at Publisher · View at Google Scholar
  5. M. J. Farrer, J. T. Stone, C.-H. Lin et al., “Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia,” Parkinsonism & Related Disorders, vol. 13, no. 2, pp. 89–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. O. A. Ross, Y.-R. Wu, M.-C. Lee et al., “Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease,” Annals of Neurology, vol. 64, no. 1, pp. 88–92, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Nalls, V. Plagnol, D. G. Hernandez et al., “Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies,” The Lancet, vol. 377, no. 9766, pp. 641–649, 2011. View at Publisher · View at Google Scholar
  8. C. M. Lill, J. T. Roehr, M. B. McQueen et al., “Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDgene database,” PLoS Genetics, vol. 8, no. 3, Article ID e1002548, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Winkler, J. Hagenah, S. Lincoln et al., “α-Synuclein and Parkinson disease susceptibility,” Neurology, vol. 69, no. 18, pp. 1745–1750, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-H. Wu-Chou, Y.-T. Chen, T.-H. Yeh et al., “Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort,” Parkinsonism and Related Disorders, vol. 19, no. 2, pp. 251–255, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Mizuta, W. Satake, Y. Nakabayashi et al., “Multiple candidate gene analysis identifies α-synuclein as a susceptibility gene for sporadic Parkinson's disease,” Human Molecular Genetics, vol. 15, no. 7, pp. 1151–1158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. D. B. Calne, B. J. Snow, and C. Lee, “Criteria for diagnosing Parkinson's disease,” Annals of Neurology, vol. 32, pp. S125–S127, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. Barrett, B. Fry, J. Maller, and M. J. Daly, “Haploview: analysis and visualization of LD and haplotype maps,” Bioinformatics, vol. 21, no. 2, pp. 263–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. D. M. Maraganore, M. De Andrade, T. C. Lesnick et al., “High-resolution whole-genome association study of Parkinson disease,” The American Journal of Human Genetics, vol. 77, no. 5, pp. 685–693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. O. A. Ross, D. Gosal, J. T. Stone et al., “Familial genes in sporadic disease: common variants of α-synuclein gene associate with Parkinson's disease,” Mechanisms of Ageing and Development, vol. 128, no. 5-6, pp. 378–382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Zimprich, S. Biskup, P. Leitner et al., “Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology,” Neuron, vol. 44, no. 4, pp. 601–607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. L. J. Ozelius, G. Senthil, R. Saunders-Pullman et al., “LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews,” The New England Journal of Medicine, vol. 354, no. 4, pp. 424–425, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Lesage, A. Dürr, M. Tazir et al., “LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs,” The New England Journal of Medicine, vol. 354, no. 4, pp. 422–423, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Kara, G. Xiromerisiou, C. Spanaki et al., “Assessment of Parkinson's disease risk loci in Greece,” Neurobiology of Aging, vol. 35, no. 2, pp. 442.e9–442.e16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. I. Soto-Ortolaza, M. G. Heckman, C. Labbé et al., “GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16,” American Journal of Neurodegenerative Disease, vol. 2, pp. 287–299, 2013. View at Google Scholar
  21. J. C. Dächsel and M. J. Farrer, “LRRK2 and Parkinson disease,” Archives of Neurology, vol. 67, no. 5, pp. 542–547, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Lesage and A. Brice, “Parkinson's disease: from monogenic forms to genetic susceptibility factors,” Human Molecular Genetics, vol. 18, no. 1, pp. R48–R59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. A. Davis, K. M. Andruska, B. A. Benitez, B. A. Racette, J. S. Perlmutter, and C. Cruchaga, “Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression,” Neurobiology of Aging, vol. 37, pp. 209.e1–209.e7, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Myhre, M. Toft, J. Kachergus et al., “Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population,” Acta Neurologica Scandinavica, vol. 118, no. 5, pp. 320–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Trotta, I. Guella, G. Soldà et al., “SNCA and MAPT genes: independent and joint effects in Parkinson disease in the Italian population,” Parkinsonism and Related Disorders, vol. 18, no. 3, pp. 257–262, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C. C. Spencer, V. Plagnol, A. Strange et al., “Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21,” Human Molecular Genetics, vol. 20, no. 2, pp. 345–353, 2011. View at Publisher · View at Google Scholar